BCL2 and lung carcinoma: si-Bcl-2 reduced the expression of antiapoptotic Bcl-2 and led to reduced cell viability in vitro of lung cancer cells when co-delivered with paclitaxel compared to paclitaxel-scrambled siRNA system.